Phenazopyridine: Difference between revisions
ClaireLewis (talk | contribs) |
|||
(5 intermediate revisions by 2 users not shown) | |||
Line 10: | Line 10: | ||
==Pediatric Dosing== | ==Pediatric Dosing== | ||
===Dysuria=== | |||
*6-12yo: 4mg/kg PO TID x 2 days | *6-12yo: 4mg/kg PO TID x 2 days | ||
*>12yo: 100-200mg PO TID x 2 days | *>12yo: 100-200mg PO TID x 2 days | ||
Line 44: | Line 44: | ||
==Adverse Reactions== | ==Adverse Reactions== | ||
===Serious=== | ===Serious=== | ||
*anaphylactoid reaction | *[[anaphylactoid reaction]] | ||
*[[Methemoglobinemia]] | *[[Methemoglobinemia]] | ||
===Common=== | ===Common=== | ||
*urine discoloration | *[[urine discoloration]] | ||
*rash | *[[rash]] | ||
* | *[[pruritus]] | ||
*nausea | *[[nausea]] | ||
*headache | *[[headache]] | ||
*dyspepsia | *[[dyspepsia]] | ||
*anemia | *[[anemia]] | ||
*anaphylaxis | *[[anaphylaxis]] | ||
*contact lens staining | *contact lens staining | ||
Line 74: | Line 74: | ||
<references/> | <references/> | ||
[[Category:Pharmacology]] | [[Category:Pharmacology]] | ||
[[Category:Urology]] |
Latest revision as of 21:31, 23 September 2019
Administration
- Type: Genitourinary
- Dosage Forms: 100, 200 mg
- Routes of Administration: PO
- Common Trade Names: Pyridium, Azo Urinary Pain Relief, Uricalm Max, Uristat
Adult Dosing
Dysuria
- 100-200mg PO TID x 2 days
Pediatric Dosing
Dysuria
- 6-12yo: 4mg/kg PO TID x 2 days
- >12yo: 100-200mg PO TID x 2 days
Special Populations
- Pregnancy Rating: B, contraindicated in pyelonephritis during pregnancy
- Lactation risk: safety unknown, inadequate literature available; caution advised
Renal Dosing
- Adult:
- CrCl 50-80: give q12-16h
- CrCl<50: contraindicated
- Pediatric:
- CrCl 50-80: give q12-16h
- CrCl<50: contraindicated
Hepatic Dosing
- Adult:
- severe hepatitis: contraindicated
- Pediatric:
- severe hepatitis: contraindicated
Contraindications
- Allergy to class/drug
- glomerulonephritis
- severe hepatitis
- uremia
- pyelonephritis during pregnancy
- renal impairment
Adverse Reactions
Serious
Common
- urine discoloration
- rash
- pruritus
- nausea
- headache
- dyspepsia
- anemia
- anaphylaxis
- contact lens staining
Pharmacology
- Half-life: unknown
- Metabolism: liver; CYP450
- Excretion: urine (65% unchanged)
- Mechanism of Action: produces topical analgesia